S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Albemarle (ALB) Stock Forecast, Price & News

-2.64 (-1.10%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.12 million shs
Average Volume
1.17 million shs
Market Capitalization
$27.69 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for Albemarle and its competitors with MarketBeat's FREE daily newsletter.

Albemarle logo

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.


See More Headlines

Industry, Sector and Symbol

Plastics materials & resins
Specialty Chemicals
Year Founded

Sales & Book Value

Annual Sales
$3.33 billion
Cash Flow
$6.20 per share
Book Value
$51.53 per share


Net Income
$123.67 million
Pretax Margin




Free Float
Market Cap
$27.69 billion

Company Calendar

Ex-Dividend for 4/1 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 7/1 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

3.00 out of 5 stars

Basic Materials Sector

13th out of 240 stocks

Plastics Materials & Resins Industry

4th out of 16 stocks

Analyst Opinion: 2.3Community Rank: 4.5Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Albemarle (NYSE:ALB) Frequently Asked Questions

Is Albemarle a buy right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Albemarle stock.
View analyst ratings for Albemarle
or view top-rated stocks.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Albemarle

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) issued its quarterly earnings data on Wednesday, May, 4th. The specialty chemicals company reported $2.38 EPS for the quarter, topping the consensus estimate of $1.73 by $0.65. The specialty chemicals company had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.03 billion. Albemarle had a net margin of 7.76% and a trailing twelve-month return on equity of 10.35%. The company's revenue was up 36.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.10 EPS.
View Albemarle's earnings history

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle declared a quarterly dividend on Tuesday, May 3rd. Stockholders of record on Friday, June 10th will be paid a dividend of $0.395 per share on Friday, July 1st. This represents a $1.58 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Thursday, June 9th.
View Albemarle's dividend history

Is Albemarle a good dividend stock?

Albemarle pays an annual dividend of $1.58 per share and currently has a dividend yield of 0.66%. Albemarle has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Albemarle is 66.39%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Albemarle will have a dividend payout ratio of 10.96% next year. This indicates that Albemarle will be able to sustain or increase its dividend.
View Albemarle's dividend history.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $9.25-$12.25 for the period, compared to the consensus estimate of $6.22. The company issued revenue guidance of $5.20 billion-$5.60 billion, compared to the consensus revenue estimate of $4.40 billion.

What price target have analysts set for ALB?

17 Wall Street analysts have issued 1 year price objectives for Albemarle's shares. Their forecasts range from $198.00 to $368.00. On average, they anticipate Albemarle's stock price to reach $277.63 in the next year. This suggests a possible upside of 17.4% from the stock's current price.
View analysts' price targets for Albemarle
or view top-rated stocks among Wall Street analysts.

Who are Albemarle's key executives?
Albemarle's management team includes the following people:
What is Luther C. Kissam, IV's approval rating as Albemarle's CEO?

63 employees have rated Albemarle CEO Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among Albemarle's employees.

What other stocks do shareholders of Albemarle own?
What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.67%), BlackRock Inc. (8.47%), State Street Corp (4.58%), Baillie Gifford & Co. (3.48%), Mirae Asset Global Investments Co. Ltd. (2.25%) and Primecap Management Co. CA (2.22%). Company insiders that own Albemarle stock include Eric Norris, J Kent Masters, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Luther C Iv Kissam, Netha N Johnson, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends for Albemarle

Which institutional investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Discovery Value Fund, First Trust Advisors LP, Cookson Peirce & Co. Inc., Bank of New York Mellon Corp, Main Street Research LLC, American Century Companies Inc., and Group One Trading L.P.. Company insiders that have sold Albemarle company stock in the last year include Eric Norris, John Clarence Barichivich III, Karen G Narwold, Raphael Goszcz Crawford, and Scott Tozier.
View insider buying and selling activity for Albemarle
or view top insider-selling stocks.

Which institutional investors are buying Albemarle stock?

ALB stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., FIFTHDELTA Ltd, Wellington Management Group LLP, Invesco Ltd., Twin Tree Management LP, AGF Investments Inc., ProShare Advisors LLC, and Moneta Group Investment Advisors LLC. Company insiders that have bought Albemarle stock in the last two years include J Kent Masters, and Netha N Johnson.
View insider buying and selling activity for Albemarle
or or view top insider-buying stocks.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $236.44.

How much money does Albemarle make?

Albemarle has a market capitalization of $27.69 billion and generates $3.33 billion in revenue each year. The specialty chemicals company earns $123.67 million in net income (profit) each year or $2.38 on an earnings per share basis.

How many employees does Albemarle have?

Albemarle employs 6,000 workers across the globe.

Does Albemarle have any subsidiaries?

The following companies are subsidiares of Albemarle: ACI Cyprus L.L.C., Albemarle (Thailand) Co. Ltd., Albemarle Argentina SRL, Albemarle Brazil Holdings LTDA., Albemarle Care Fund, Albemarle Catalysts Company B.V., Albemarle Chemical Canada Ltd., Albemarle Chemicals (Shanghai) Co. Ltd., Albemarle Chemicals Ltd., Albemarle Chemicals Private Limited, Albemarle Chemicals S.A.S., Albemarle Chemicals South Africa (Proprietary) Limited, Albemarle Delaware Holdings 1 LLC, Albemarle Delaware Holdings 2 LLC, Albemarle Dutch Holdings 2 B.V., Albemarle Dutch Holdings B.V., Albemarle Europe SRL, Albemarle Finance Company B.V., Albemarle Foundation, Albemarle Germany Gmbh, Albemarle Hilfe GmbH Unterstützungskasse, Albemarle Holdings Company Limited, Albemarle Holdings Limited, Albemarle Hungary Ltd., Albemarle Italy S.R.L., Albemarle Japan Corporation, Albemarle Japan Holdings B.V., Albemarle Knight Lux 1 Holdings Corporation, Albemarle Korea Corporation, Albemarle Limitada, Albemarle Lithium Holding Corporation, Albemarle Lithium Holding GmbH, Albemarle Lithium Pty Ltd, Albemarle Malaysia Sdn Bhd, Albemarle Management (Shanghai) Co. Ltd., Albemarle Middle East FZE, Albemarle Netherlands B.V., Albemarle New Holding GmbH, Albemarle Overseas Employment Corporation, Albemarle Quimica LTDA, Albemarle Saudi Trading Company, Albemarle Singapore Pte. Ltd., Albemarle Spain S.L., Albemarle Taiwan Limited, Albemarle U.S. Inc., Albemarle Vietnam Limited Liability Company, Albemarle Wodgina Pty Ltd, Albemarle de Venezuela C.A., Dynamit Nobel GmbH, Dynamit Nobel Unterstützungsfonds GmbH, Excalibur II Realty Company, Excalibur Realty Company, Foote Chile Holding Company, Foote Minera e Inversiones Ltda., Jiangxi Albemarle Lithium Co. Ltd., Jordan Bromine Company Limited, Knight Lux 1 S.à r.l., Knight Lux 2 S.à r.l., MARBL Lithium Operations Pty Ltd, Metalon Environmental Management & Solutions GmbH, PT Albemarle Chemicals Indonesia, RSG Immobilien GmbH, RT Lithium Limited, Rockwood Holdings, Rockwood Holdings Inc., Rockwood Lithium (Shanghai) Co. Ltd., Rockwood Lithium India Pvt. Ltd., Rockwood Lithium Japan K.K., Rockwood Lithium Korea LLC, Rockwood Lithium Taiwan Co. Ltd., Rockwood Specialties GmbH, Rockwood Specialties Group LLC, Rockwood Specialties LLC, Rockwood Specialties Limited, Sales de Magnesio Limitada, Shandong Sinobrom Albemarle Bromine Chemicals Company Limited, and Sichuan Guorun New Material Co. Ltd..

When was Albemarle founded?

Albemarle was founded in 1994.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at (980) 299-5700, via email at [email protected], or via fax at 225-388-7686.

This page was last updated on 5/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.